Oruka Therapeutics, Inc. Operating Lease, Liability, Current
Oruka Therapeutics, Inc. (ORKA) had Operating Lease, Liability, Current of $669.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-10
- 2026-06-30: Operating Lease, Liability, Current $669.00K.
- 2026-03-31: Operating Lease, Liability, Current $680.00K.
- 2025-12-31: Operating Lease, Liability, Current $619.00K.
- 2025-09-30: Operating Lease, Liability, Current $419.00K.
| Period end | Operating Lease, Liability, Current | Operating Lease, Liability, Current as first filed |
|---|---|---|
| 2026-06-30 | $669.00K 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $680.00K 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $619.00K 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $419.00K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $660.00K 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $283.00K 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $213.00K 10-K · filed 2026-03-12 | |
| 2024-09-30 | $146.00K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $24.00K 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $48.00K 10-Q · filed 2024-04-25 | |
| 2023-12-31 | $76.00K 10-K · filed 2024-02-01 | |
| 2023-09-30 | $77.00K 10-Q · filed 2023-10-18 | |
| 2023-06-30 | $86.00K 10-Q · filed 2023-07-21 | |
| 2023-03-31 | $95.00K 10-Q · filed 2023-04-24 | |
| 2022-12-31 | $103.00K 10-K · filed 2023-02-24 | |
| 2022-09-30 | $108.00K 10-Q · filed 2022-10-28 | |
| 2022-06-30 | $106.00K 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $103.00K 10-Q · filed 2022-05-02 | |
| 2021-12-31 | $100.00K 10-K · filed 2022-03-14 | |
| 2021-09-30 | $97.00K 10-Q · filed 2021-11-02 | |
| 2021-06-30 | $87.00K 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $56.00K 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $41.00K 10-K · filed 2021-03-18 | |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-02 | |
| 2020-06-30 | $25.00M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $50.00M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $25.00M 10-Q · filed 2020-11-02 | $25.00K 10-K · filed 2020-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Veradermics, Inc (MANE) | United States | $4.839B |